Arterial calcification of infancy: Clinical Trials

3 trials for Arterial calcification of infancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 22Completed 2

Follow Arterial calcification of infancy: new trials by email Literature Review of Arterial calcification of infancy trials Research Report on Arterial calcification of infancy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
INZ-701 - Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets
Phase 1TerminatedInozyme Pharma92023-06-252026-10-15
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE
INZ-701 - ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum
Phase 1 / Phase 2CompletedInozyme Pharma102022-04-112026-10-13
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency
INZ-701 - Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets
Phase 1 / Phase 2CompletedInozyme Pharma132021-11-212026-10-27

Narrower conditions

Hypophosphatemic Rickets, Autosomal Recessive, 1 (2)  ·  Pseudoxanthoma Elasticum (2)

Broader conditions

Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Connective Tissue Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Skin Abnormalities (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Vascular Diseases (2)

Sponsors

Inozyme Pharma (3)

Countries

United Kingdom (3)  ·  United States (3)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Spain (1)